National Pharmaceuticals Pricing Authority has directed pharma companies to cut MRPs of 17 drugs after the Budget 2026-27 exempted them…
India and the US have signed an interim trade pact cutting tariffs to 18%, with zero-duty benefits for pharma, gems,…
In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance…
The company’s strong performance was driven by growth in key therapy areas across both domestic and international markets, particularly in…
Post-Budget trends signal near-term dips across 8 key Nifty sectors; review support and resistance levels before making investment decisions.
Cipla shares tanked over 5% after Nuvama slashed its target and flagged five new red alerts — from USFDA scrutiny…
Union Budget 2026 is expected to prioritise consumption, railways, MSMEs, defence and green energy as FM Sitharaman presents her ninth…
Market Master Vijay Kedia just made his first big move for 2026, and it has already created a buzz in…
IPO funds used mainly for promoter exits, not assets—see Sanjeev Prasad’s 2026 outlook and market drivers. Read key insights now!
A revolution in India’s weight-loss market is coming. As Semaglutide’s patent ends in 2026, Sun Pharma, Lupin, Torrent, and Intas…
Ajanta Pharma eyes new growth with anti-obesity pivot; Motilal Oswal sees 17% upside—read why you should consider this stock now.
Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to manufacturing-related quality…
The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…
Mehta said India has nearly 254 million people living with generalised obesity and another 351 million with abdominal obesity. “The…
Corona Remedies listed at a 38% premium on NSE and BSE after Rs 655.37 crore IPO; check latest share price…
Corona Remedies IPO Allotment Live | Corona Remedies IPO Allotment Status Link, Listing Date, GMP Today, Refund, Demat Credit &…
” We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger…
Sudeep Pharma Share Price, IPO Listing Live | Sudeep Pharma IPO GMP Live Updates: Sudeep Pharma debuts on stock exchanges…

Bangladesh is getting ready for its first national parliamentary election since Sheikh Hasina was ousted as the Prime Minister in August 2024 after massive student-led protests. Since then, the country has been led by interim chief Muhammad Yunus. The past months have been tense, marked by large protests, clashes in several areas, and damage to public property.